China Reinsurance (Group) Corp is a Chinese company that is engaged in the reinsurance business. It provides various products and services including reinsurance, direct insurance, asset management, insurance brokerage, and insurance media service. The company offers a variety of reinsurance products for various property and casualty insurance, such as motor, property, agricultural, liability insurance, life, health, accident insurance, and asset management services. It operates through the following business segments: Property and casualty reinsurance, Life and health reinsurance, Primary property and casualty insurance, Asset Management, and Others.
1949
50.0K+
LTM Revenue $17.5B
LTM EBITDA n/a
$4.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
China Re has a last 12-month revenue of $17.5B and a last 12-month EBITDA of n/a.
In the most recent fiscal year, China Re achieved revenue of $13.1B and an EBITDA of n/a.
China Re expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See China Re valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $21.6B | $13.1B | XXX | XXX | XXX |
Gross Profit | n/a | n/a | XXX | XXX | XXX |
Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
EBITDA | n/a | n/a | XXX | XXX | XXX |
EBITDA Margin | NaN% | NaN% | XXX | XXX | XXX |
Net Profit | $818M | $241M | XXX | XXX | XXX |
Net Margin | 4% | 2% | XXX | XXX | XXX |
Net Debt | $381M | $261M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, China Re's stock price is HKD 1 (or $0).
China Re has current market cap of HKD 36.1B (or $4.6B), and EV of HKD 37.1B (or $4.8B).
See China Re trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$4.8B | $4.6B | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, China Re has market cap of $4.6B and EV of $4.8B.
China Re's trades at 0.3x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate China Re's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for China Re and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $4.8B | XXX | XXX | XXX |
EV/Revenue | 0.4x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | 6.4x | XXX | XXX | XXX |
P/E/Growth | 0.2x | XXX | XXX | XXX |
EV/FCF | 2.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpChina Re's NTM/LTM revenue growth is 2%
China Re's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged n/a for the same period.
Over next 12 months, China Re's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate China Re's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for China Re and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -39% | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Arab Insurance Group | XXX | XXX | XXX | XXX | XXX | XXX |
General Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
IRB(Re) | XXX | XXX | XXX | XXX | XXX | XXX |
Qatar Insurance Group | XXX | XXX | XXX | XXX | XXX | XXX |
Hannover Re | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
China Re acquired XXX companies to date.
Last acquisition by China Re was XXXXXXXX, XXXXX XXXXX XXXXXX . China Re acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was China Re founded? | China Re was founded in 1949. |
Where is China Re headquartered? | China Re is headquartered in Hong Kong. |
How many employees does China Re have? | As of today, China Re has 50.0K+ employees. |
Is China Re publicy listed? | Yes, China Re is a public company listed on HKG. |
What is the stock symbol of China Re? | China Re trades under 01508 ticker. |
When did China Re go public? | China Re went public in 2015. |
Who are competitors of China Re? | Similar companies to China Re include e.g. Arab Insurance Group, General Insurance, IRB(Re), Qatar Insurance Group. |
What is the current market cap of China Re? | China Re's current market cap is $4.6B |
What is the current revenue of China Re? | China Re's last 12-month revenue is $17.5B. |
What is the current EV/Revenue multiple of China Re? | Current revenue multiple of China Re is 0.3x. |
What is the current revenue growth of China Re? | China Re revenue growth between 2023 and 2024 was -39%. |
Is China Re profitable? | Yes, China Re is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.